Abstract: Systems and method in accordance with the embodiments of the present invention can include an implant for positioning within a cervical facet joint for distracting the cervical spine, thereby increasing the area of the canals and openings through which the spinal cord and nerves must pass, and decreasing pressure on the spinal cord and/or nerve roots. The implant can be inserted laterally or posteriorly.

Abstract: Systems and method in accordance with the embodiments of the present invention can include an implant for positioning within a cervical facet joint for distracting the cervical spine, thereby increasing the area of the canals and openings through which the spinal cord and nerves must pass, and decreasing pressure on the spinal cord and/or nerve roots. The implant can be inserted laterally or posteriorly.

Abstract: Systems and method in accordance with the embodiments of the present invention can include an implant for positioning within a cervical facet joint for distracting the cervical spine, thereby increasing the area of the canals and openings through which the spinal cord and nerves must pass, and decreasing pressure on the spinal cord and/or nerve roots. The implant can be inserted laterally or posteriorly.

Abstract: Systems and method in accordance with the embodiments of the present invention can include an implant for positioning within a cervical facet joint for distracting the cervical spine, thereby increasing the area of the canals and openings through which the spinal cord and nerves must pass, and decreasing pressure on the spinal cord and/or nerve roots. The implant can be inserted laterally or posteriorly.

Abstract: Systems and method in accordance with the embodiments of the present invention can include an implant for positioning within a cervical facet joint for distracting the cervical spine, thereby increasing the area of the canals and openings through which the spinal cord and nerves must pass, and decreasing pressure on the spinal cord and/or nerve roots. The implant can be inserted laterally or posteriorly.

Abstract: Text is converted to speech based at least in part on the context of the text. A body of text may be parsed before being converted to speech. Each portion may be analyzed to determine whether it has one or more particular attributes, which may be indicative of context. The conversion of each text portion to speech may be controlled based on these attributes, for example, by setting one or more conversion parameter values for the text portion. The text portions and the associated conversion parameter values may be sent to a text-to-speech engine to perform the conversion to speech, and the generated speech may be stored as an audio file. Audio markers may be placed at one or more locations within the audio file, and these markers may be used to listen to, navigate and/or edit the audio file, for example, using a portable audio device.

Abstract: Systems in accordance with embodiments of the present invention can include an implant comprising a spacer for defining a minimum space between adjacent spinous processes, a distraction guide for piercing and distracting an interspinous ligament during implantation, and a binder for limiting or preventing flexion motion of the targeted motion segment. The binder can be secured to a brace associated with the implant during implantation by a capture device. In one embodiment, the capture device includes a fixed piece extending from the brace and a slidable piece associated with the fixed piece. A fastener can be rotated to pinch the binder between the slidable piece and a wall of the brace, securing the binder. A physician need not know the length of the binder prior to implantation, reducing the time required to perform a procedure.

Abstract: Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed “STEAP” (Six Transmembrane Epithelial Antigen of the Prostate). Four particular human STEAPs are described and characterized herein. The human STEAPs exhibit a high degree of structural conservation among them but show no significant structural homology to any known human proteins. The prototype member of the STEAP family, STEAP-1, appears to be a type IIIa membrane protein expressed predominantly in prostate cells in normal human tissues. Structurally, STEAP-1 is a 339 amino acid protein characterized by a molecular topology of six transmembrane domains and intracellular N- and C-termini, suggesting that it folds in a “serpentine” manner into three extracellular and two intracellular loops.

Abstract: An intervertebral disk implant is adapted to be placed between two vertebrae using a lateral insertion method. The implant is characterized by features including a first end plate having a first socket and a second end plate having a second socket with a spacer that is at least partially received in the first socket and the second socket. The implant includes at least one keel that is adapted to be inserted laterally into a vertebral body of the spine. The spacer allows for pivotal or rotational motion and also for twisting motion of the spine once the implant is inserted between vertebrae of a patient.

Abstract: The present invention is directed to an implant that can be placed between two adjacent vertebral bodies using a lateral insertion method. The implant is characterized as having a first end plate and a second end plate which a crossbar spacer therebetween. The crossbar spacer preferably fits within a channel on the inner surfaces of the first end plate and the second end plate, whereby the spacer allows pivots, twisting and/or rotational movement of the spine. The first end plate and the second end plate include a keel extending therefrom, whereby the keel traverses longitudinally between a first lateral side and a second opposed lateral side and is substantially perpendicular to the sagittal plane of the patient's spine.

Abstract: In an exemplary embodiment, an augmented reality system for traffic control combines data from a plurality of sensors to display, in real time, information about traffic control objects, such as airplanes. The sensors collect data, such as infrared, ultraviolet, and acoustic data. The collected data is weather-independent due to the combination of different sensors. The traffic control objects and their associated data are then displayed visually to the controller regardless of external viewing conditions. The system also responds to the controller's physical gestures or voice commands to select a particular traffic control object for close-up observation or to open a communication channel with the particular traffic control object.

Abstract: A novel gene (designated 121P2A3) and its encoded protein, and variants thereof, are described wherein 121P2A3 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 121P2A3 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 121P2A3 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 121P2A3 can be used in active or passive immunization.

Abstract: An implant that can be placed between two vertebrae using a lateral insertion method is described. The implant is characterized by having a first end plate and a second end plate with a hemi-cylindrical spacer extending from the second end plate. The hemi-cylindrical spacer fits within a socket on the first end plate and allows for pivotal or rotational motion and also for twisting motion.

Abstract: An implant that can be placed between two vertebrae using a lateral insertion method is described. The implant is characterized by having a first end plate and a second end plate with a hemi-cylindrical spacer extending from the second end plate. The hemi-cylindrical spacer fits within a socket on the first end plate and allows for pivotal or rotational motion and also for twisting motion.

Abstract: The present invention is directed to an implant that can be placed between two adjacent vertebral bodies using a lateral insertion method. The implant is characterized as having a first end plate and a second end plate which a crossbar spacer therebetween. The crossbar spacer preferably fits within a channel on the inner surfaces of the first end plate and the second end plate, whereby the crossbar spacer allows pivots, twisting and/or rotational movement of the spine. The first end plate and the second end plate include a keel extending therefrom, whereby the keel traverses longitudinally between a first lateral side and a second opposed lateral side and is substantially perpendicular to the sagittal plane of the patient's spine.

Abstract: The present invention is directed to an implant that can be placed between two adjacent vertebral bodies using a lateral insertion method. The implant is characterized as having a first end plate and a second end plate which a crossbar spacer therebetween. The crossbar spacer preferably fits within a channel on the inner surfaces of the first end plate and the second end plate, whereby the spacer allows pivots, twisting and/or rotational movement of the spine. The first end plate and the second end plate include a keel extending therefrom, whereby the keel traverses longitudinally between a first lateral side and a second opposed lateral side and is substantially perpendicular to the sagittal plane of the patient's spine.

Abstract: The present invention relates to a novel protein designated 20P2H8 which shares homology with several heterogeneous nuclear ribonucleoproteins (hnRNPs). A full length approximately 3600 bp 20P2H8 cDNA (SEQ ID NO: 1, encoding a 517 amino acid open reading frame (SEQ ID NO: 2), is provided herein.

Abstract: Described is a novel family of cell surface serpentine transmembrane antigens. Two of the proteins in this family are exclusively or predominantly expressed in the prostate, as well as in prostate cancer, and thus members of this family have been termed “STEAP” (Six Transmembrane Epithelial Antigen of the Prostate). Four particular human STEAPs are described and characterized herein. The human STEAPs exhibit a high degree of structural conservation among them but show no significant structural homology to any known human proteins. The prototype member of the STEAP family, STEAP-1, appears to be a type IIIa membrane protein expressed predominantly in prostate cells in normal human tissues. Structurally, STEAP-1 is a 339 amino acid protein characterized by a molecular topology of six transmembrane domains and intracellular N- and C-termini, suggesting that it folds in a “serpentine” manner into three extracellular and two intracellular loops.